Programme and Management Contacts
Programme Management Team – via SER CMYRU
COMMITTEES AND PANELS
Independent Evaluation Panel: This will function in a similar manner to a research board of a national Research Council and all scientific decisions will be made on the basis of merit, as assessed by peer review, with no ministerial or civil service input. Members of the scientific and business community will be asked to consider fellowship applications once yearly in the first three years of the five year SIRCIW. The panel was recruited through an open and transparent competition.
Membership is given in the table below. This Panel will ensure compliance with strict governance protocols, in line with the guidelines followed by UK Research Councils, and pay particular attention to appropriately addressing conflicts of interest. Each panel member will act as rapporteur for one or more proposals at the panel meeting, giving their comments and scores on each.
Chair, Independent Consultant in Biomedicine, former Deputy CEO, MRC
Emeritus Professor, UNSW, Australia
Coleg Gwledig Yr Alban, Caeredin
Emeritus Professor, King's College London
Emeritus Professor, Bristol University
Entrepreneur and Visiting Professor (UCL & Reading)
Head of Dept of Biochemistry, University of Liverpool
Professor of Midwifery, Ulster University
Xiao Yun Xu
Professor, Chemical Engineering, Imperial College London
Professor, School of Engineering and Computer Sciences, Durham
Emeritus Professor, University of Edinburgh
Professor, Dept of Computer Science, University of Chester
Independent Energy Consultant
Professor of Public Health and Dean of Research, Brunel University
Programme Beneficiary Board: The ‘Programme Beneficiary Board’ will be chaired by Professor Julie Williams CBE, Chief Scientific Adviser for Wales (CSAW). Professor Williams is one of the UK’s leading figures in Alzheimer’s research. She has joined, headed and established a number of powerful large consortia and sample collections; has been Dean of Research and has served on numerous advisory boards e.g. the MRC and as Chief Scientific advisor to Alzheimer’s Research UK (ARUK). She has received research funding from Wellcome Trust, MRC, EU, the Health Foundation and ARUK and has ongoing collaborations with commercial partners such as Araclon Biotech; Proteome Sciences, GSK, Millipore and SomaLogic.
Other members could include senior Welsh Government staff e.g. WG’s Head of Science Division; Chief Executive HEFCW; and the Pro-Vice Chancellors for Research of the partner universities.
Responsible Research and Innovation (RRI) Oversight Group: This will be a group of three people with experience of sitting on ethical review panels and/or expertise in equality and diversity issues. This group will oversee the management of ethical issues and receive annual reports on the way RRI issues are being addressed through the programme and by individual awarded fellowships. It will be appointed soon through open and transparent competition